The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future

Author(s): Zhaoyuan Xu, Guohua Ji, Ying Cui, Xiaobo Cui*

Journal Name: Current Cancer Drug Targets

Volume 21 , Issue 5 , 2021


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

N6-methyladenosine (m6A) modifications control multifaceted RNA metabolism and are one of the most extensively distributed modifications on the human transcriptome, including non-coding RNAs (ncRNAs). Previous concepts of ncRNAs as “junk” transcriptional products have evolved to the concept that ncRNAs are functional regulatory molecules that determine specific biological processes and cell fates. The dysregulation of m6A modifications and ncRNAs have been implicated in the development of human carcinogenesis. Certain types of ncRNAs have been reported to exert regulatory effects on m6A machinery. However, a better understanding of the relationship between m6A modifications and ncRNAs in cancer is still needed. This review discusses mutual interactions between m6A modifications and ncRNAs and their impacts on the development of human cancer. We summarize the clinical significance of m6A-ncRNA networks for cancer diagnosis and treatment, and we ask challenging questions that remain unanswered in this field of research. Understanding the complex coordination between m6A modifications and ncRNAs will be useful for guiding the development of therapeutic interventions.

Keywords: N6-methyladenosine, miRNA, LncRNA, CircRNA, PiRNA, non-coding RNA, cancer.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 5
Year: 2021
Published on: 20 January, 2021
Page: [375 - 385]
Pages: 11
DOI: 10.2174/1568009621999210120193636
Price: $65

Article Metrics

PDF: 141